Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

4-MeO-DiPT

From Wikipedia, the free encyclopedia
Chemical compound

Pharmaceutical compound
4-MeO-DiPT
Clinical data
Other names4-OMe-DiPT; 4-Methoxy-N,N-diisopropyltryptamine; D-4200;N,N-Diisopropyl-4-methoxytryptamine
Drug classNon-selectiveserotonin receptor agonist;Serotonin 5-HT2A receptor agonist;Serotonin reuptake inhibitor
ATC code
  • None
Identifiers
  • N-Isopropyl-N-[2-(4-methoxy-1H-indol-3-yl)ethyl]-2-propanamine
PubChemCID
ChemSpider
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC17H26N2O
Molar mass274.408 g·mol−1
3D model (JSmol)
  • CC(C)N(CCC1=CNC2=C1C(=CC=C2)OC)C(C)C
  • InChI=1S/C17H26N2O/c1-12(2)19(13(3)4)10-9-14-11-18-15-7-6-8-16(20-5)17(14)15/h6-8,11-13,18H,9-10H2,1-5H3
  • Key:WIVWUNUDMXNQJD-UHFFFAOYSA-N

4-MeO-DiPT, also known as4-methoxy-N,N-diisopropyltryptamine, is a novelserotonin receptor modulator of thetryptamine family related to knownpsychedelic tryptamines likepsilocin (4-HO-DMT) and5-MeO-DMT.[1][2] It is the 4-methoxyanalog ofDiPT and theO-methylether of4-HO-DiPT.[1] Very little data exists about the human use,metabolism, andtoxicity of 4-MeO-DiPT.[1][2]

Use and effects

[edit]

4-MeO-DiPT is not known to have been assessed in humans.[2] It is unknown whether the drug producespsychedelic effects in humans.[2]

Interactions

[edit]
See also:Psychedelic drug § Interactions, andTrip killer § Serotonergic psychedelic antidotes

Pharmacology

[edit]

Pharmacodynamics

[edit]
4-MeO-DiPT activities
TargetAffinity (Ki, nM)
5-HT1A2,830 (Ki)
1,930 (EC50Tooltip half-maximal effective concentration)
113% (EmaxTooltip maximal efficacy)
5-HT2A500 (Ki)
870a (EC50)
92%a (
Emax)
5-HT2C833 (Ki)
179a (EC50)
85%a (
Emax)
SERT12 (Ki)
11 (IC50)
Notes: The smaller the value, the more avidly the drug interacts with the site.Footnotes:a = Stimulation ofIP1Tooltip inositol phosphate formation.Sources:[1]

4-MeO-DiPT acts as aserotonin reuptake inhibitor andnon-selectiveserotonin receptor agonist, including of theserotonin5-HT2A, and5-HT2C receptors.[1] It shows the highestpotency as a serotonin reuptake inhibitor with 40- to 50-foldselectivity for theserotonin transporter (SERT) over the 5-HT2A receptor, moderate potency as anagonist of the 5-HT2C receptor, and low potency with highefficacy as an agonist of the5-HT1A receptor.[1] Affinities towardsreceptors outside of theserotonin receptor family have not yet been assessed.[1]

Increasedextracellularconcentrations of serotonin, resulting from SERTblockade, similarly to4-MeO-MiPT may compete at 5-HT2A, altering or blunting effects mediated by this receptor.[1] This profile makes 4-MeO-DiPT a potential candidate for elucidating the role of SERT blockade in the mechanisms underlyingserotonergic psychedelic action.[1]

Chemistry

[edit]

4-MeO-DiPT is asyntheticderivative of thesubstituted tryptamine and4-methoxytryptamine families.[1][2] It is the 4-methoxyanalogue ofN,N-diisopropyltryptamine (DiPT) and theO-methylether of4-HO-DiPT.[1][2][3]

Analogues

[edit]

Analogues of 4-MeO-DiPT includeN,N-diisopropyltryptamine (DiPT),4-methoxytryptamine (4-MeO-T),4-MeO-MiPT,4-MeO-DMT,4-HO-DiPT,4-AcO-DiPT,5-MeO-DiPT,5-MeO-DMT, andpsilocin (4-HO-DMT), among others.[1][2][3]

History

[edit]

4-MeO-DiPT was briefly mentioned byAlexander Shulgin in his 1997 bookTiHKAL (Tryptamines I Have Known Loved).[2] Subsequently, it was described and studied further in the early 2020s.[3][1]

Society and culture

[edit]

Legal status

[edit]

United States

[edit]

4-MeO-DiPT is not an explicitlycontrolled substance in theUnited States, but may be considered aSchedule I controlled substance in this country as it is apositional isomer of5-MeO-DiPT.[4][5]

See also

[edit]

References

[edit]
  1. ^abcdefghijklmKozell LB, Eshleman AJ, Swanson TL, Bloom SH, Wolfrum KM, Schmachtenberg JL, et al. (April 2023)."Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2A Receptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin Transporter".The Journal of Pharmacology and Experimental Therapeutics.385 (1):62–75.doi:10.1124/jpet.122.001454.PMC 10029822.PMID 36669875.
  2. ^abcdefghShulgin A,Shulgin A (September 1997).TiHKAL: The Continuation.Berkeley, California:Transform Press.ISBN 0-9630096-9-9.OCLC 38503252. "The 5-MeO-DMT has already been mentioned, and the remaining two would be 4-MeO-DMT and 4-MeO-DIPT. The former is a known compound but has not been measured in man. The latter is not a known compound."
  3. ^abcLee HZ, Ng JY, Ong MC, Lim JL, Yap TW (November 2020). "Technical note: Unequivocal identification of 5-methoxy-DiPT with NOESY NMR and GC-IRD".Forensic Science International.316 (110537) 110537.doi:10.1016/j.forsciint.2020.110537.PMID 33099269.
  4. ^Orange Book: List of Controlled Substances and Regulated Chemicals (January 2026)(PDF),United States: U.S.Department of Justice:Drug Enforcement Administration (DEA): Diversion Control Division, January 2026
  5. ^Drug Enforcement Administration (3 December 2007)."Definition of "Positional Isomer" as It Pertains to the Control of Schedule I Controlled Substances".Federal Register.

External links

[edit]
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
DATTooltip Dopamine transporter
(DRIsTooltip Dopamine reuptake inhibitors)
NETTooltip Norepinephrine transporter
(NRIsTooltip Norepinephrine reuptake inhibitors)
SERTTooltip Serotonin transporter
(SRIsTooltip Serotonin reuptake inhibitors)
VMATsTooltip Vesicular monoamine transporters
Others
Tryptamines
4-Hydroxytryptamines
andesters/ethers
5-Hydroxy- and
5-methoxytryptamines
N-Acetyltryptamines
α-Alkyltryptamines
α-Ketotryptamines
Cyclized tryptamines
Isotryptamines
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=4-MeO-DiPT&oldid=1338080878"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp